PAUL COLVIN Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL COLVIN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL COLVIN. PAUL COLVIN is EVP--Clinical Development in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Pres., Clinical Solutions in Syneos Health, Inc. ($INCR).

Latest Insider Trading Transactions of PAUL COLVIN

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, PPDI, INCR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 04 2021INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...GrantA0.001,048030,95229.9 K to 31 K (+3.50 %)
Mar 04 2021INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...GrantA0.001,629029,90428.3 K to 29.9 K (+5.76 %)
Feb 03 2021INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...SellS74.828,486634,92328,27536.8 K to 28.3 K (-23.08 %)
Jan 20 2021INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...GrantA0.0011,463036,76125.3 K to 36.8 K (+45.31 %)
Jan 20 2021INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...Payment of ExerciseF75.421,768133,34325,29827.1 K to 25.3 K (-6.53 %)
Jan 11 2021INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...Payment of ExerciseF73.592,031149,46127,06629.1 K to 27.1 K (-6.98 %)
Apr 15 2020INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...GrantA0.002,491029,34626.9 K to 29.3 K (+9.28 %)
Mar 23 2020INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...BuyP36.651,30047,64526,85525.6 K to 26.9 K (+5.09 %)
Jan 17 2020INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...GrantA0.0011,862025,55513.7 K to 25.6 K (+86.63 %)
Jan 09 2020INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...Payment of ExerciseF59.961,40484,18413,69315.1 K to 13.7 K (-9.30 %)
Jan 03 2020INCRSyneos Health, Inc ...COLVIN PAULPres., Clinical Sol ...Payment of ExerciseF59.5124914,81815,09715.3 K to 15.1 K (-1.62 %)
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD0.0010,00000
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD37.5131,0521,164,7610
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD43.2615,526671,6550
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD37.6911,386429,1380
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD25.7415,992411,6340
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD26.6416,000426,2400
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD27.2730,000818,1000
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD20.4511,041225,7880
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseD19.943,75374,8350
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...SellD33.25451,496045 to 0 (-100.00 %)
Dec 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...BuyI24.98205004525 to 45 (+80.00 %)
Jul 06 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...BuyI24.1624580240 to 24
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseM20.455,333109,06011,041
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseM19.943266,5003,753
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseM19.941001,9944,079
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...SellS28.705,659162,41305.7 K to 0 (-100.00 %)
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...BuyM20.455,333109,0605,659326 to 5.7 K (+1,635.89 %)
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...BuyM19.943266,5003260 to 326
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...SellS28.701002,8700100 to 0 (-100.00 %)
May 27 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...BuyM19.941001,9941000 to 100
May 23 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseM20.451873,82416,374
May 23 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseM19.944138,2354,179
May 23 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...SellS29.0160017,4060600 to 0 (-100.00 %)
May 23 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...BuyM20.451873,824600413 to 600 (+45.28 %)
May 23 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...BuyM19.944138,2354130 to 413
Feb 25 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseA0.0010,000010,000
Feb 25 2011PPDIPHARMACEUTICAL PRO ...COLVIN PAULEVP--Clinical Devel ...Option ExerciseA27.2730,000818,10030,000

Page:   1